Renal Cell Carcinoma

Cancer detection firm Elypta awarded quality certification

By LabPulse.com staff writers

The scope of the certification includes the design and development of in vitro diagnostic (IVD) test kits and software for Elypta’s liquid biopsy-based platform for the detection and measurement of glycosaminoglycans (GAGomes) across different cancers.

July 7, 2023

AI-driven DNA methylation liquid biopsy shows promise in brain and kidney cancer

By Emily Hayes

The method -- called cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq) -- has been developed for blood and other kinds of liquid specimens. Testing screens for abnormal methylation, whereas liquid biopsy tests typically look for mutations, the researchers explained.

June 23, 2020

Google reports pathology AI helps predict survival in cancer patients

By Emily Hayes

The deep-learning system was developed and tested using histopathology slides for patients with 10 cancer types -- including bladder cancer, invasive breast cancer, and head and neck squamous cell carcinoma -- drawing from publicly available data from the Cancer Genome Atlas (TCGA) program.

June 17, 2020